Turkish Thoracic Journal

Scope & Guideline

Advancing pulmonary health through innovative research.

Introduction

Delve into the academic richness of Turkish Thoracic Journal with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageTurkish
ISSN-
PublisherAVES
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationTURK THORAC J / Turk. Thorac. J.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, Turkiye

Aims and Scopes

The Turkish Thoracic Journal focuses on a broad spectrum of research related to thoracic diseases, with an emphasis on clinical, epidemiological, and therapeutic aspects of respiratory conditions. The journal serves as a platform for advancing knowledge in pulmonary medicine through original research, reviews, case reports, and clinical studies.
  1. Pulmonary Diseases and Disorders:
    The journal extensively covers various pulmonary conditions including Chronic Obstructive Pulmonary Disease (COPD), asthma, lung cancer, and interstitial lung diseases, providing insights into their pathophysiology, diagnosis, and management.
  2. Impact of COVID-19 on Respiratory Health:
    A significant focus has been placed on understanding the implications of COVID-19 on lung health, including studies on pneumonia, pulmonary rehabilitation, and the long-term effects of the virus on respiratory function.
  3. Epidemiological Studies and Public Health:
    The journal publishes research on the epidemiology of respiratory diseases, highlighting risk factors, prevalence, and the impact of environmental factors such as air pollution and tobacco use.
  4. Innovative Therapeutic Approaches:
    Research on novel treatment strategies and therapeutic interventions for respiratory diseases, including the use of biologics, stem cells, and novel drug delivery systems, is a key aspect of the journal.
  5. Clinical Guidelines and Best Practices:
    The journal aims to disseminate clinical guidelines and evidence-based practices for the management of various respiratory conditions, enhancing the quality of care in pulmonary medicine.
The Turkish Thoracic Journal has notably adapted to emerging health concerns, particularly those arising from the COVID-19 pandemic. Recent publications showcase a shift towards innovative research themes that are gaining traction in thoracic medicine.
  1. Post-COVID-19 Pulmonary Health:
    A surge in studies addressing the long-term pulmonary effects of COVID-19, including post-COVID pulmonary rehabilitation and functional evaluations, reflects a growing concern for survivors of the virus.
  2. Environmental and Societal Impacts on Respiratory Health:
    Increasing attention is being directed towards the impact of environmental factors, such as air pollution and climate change, on respiratory diseases, with calls for urgent action highlighted in recent publications.
  3. Telemedicine and Remote Patient Management:
    The rise of telemedicine as a tool for managing respiratory conditions, particularly during the COVID-19 pandemic, indicates a trend towards integrating technology in patient care and follow-up.
  4. Research on New Tobacco Products:
    There is a noticeable increase in studies focusing on the health effects of electronic cigarettes and heated tobacco products, reflecting the evolving landscape of tobacco use and its implications for lung health.
  5. Mental Health and Respiratory Conditions:
    Emerging themes include the psychological impact of respiratory diseases and the pandemic on patients, indicating a growing recognition of the interplay between mental health and respiratory health.

Declining or Waning

While the Turkish Thoracic Journal continues to evolve, certain traditional themes are becoming less prominent in recent publications. This decline may reflect shifting research priorities or emerging health challenges.
  1. Traditional Smoking Cessation Strategies:
    Research focusing on conventional smoking cessation methods appears to be waning, possibly as newer approaches and technologies gain traction in the field of tobacco control.
  2. Occupational Lung Diseases:
    Although still relevant, the frequency of studies specifically addressing occupational lung diseases, such as asbestosis and silicosis, has decreased, potentially overshadowed by the urgent focus on COVID-19 and its respiratory implications.
  3. Historical Case Reports:
    The publication of historical case reports related to pulmonary diseases seems to be declining, as the journal's emphasis shifts towards contemporary studies and clinical trials.
  4. Pediatric Respiratory Conditions:
    Research centered on pediatric lung diseases, while still important, appears to have diminished in frequency, possibly due to a broader focus on adult respiratory conditions in the context of the pandemic.

Similar Journals

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine

Unlocking Vital Research in Circulatory and Respiratory Medicine
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5484Frequency: 1 issue/year

Clinical Medicine Insights-Circulatory Respiratory and Pulmonary Medicine, published by SAGE Publications Ltd, stands as a vital resource in the fields of Cardiology and Pulmonary Medicine, underscored by its Q3 quartile rankings in both areas for 2023. Established in 2007 as an open-access journal, it facilitates the dissemination of cutting-edge research and observations from the international scientific community. With an ISSN of 1179-5484, the journal has garnered recognition for its contributions to clinical medicine, particularly covering topics of circulatory, respiratory, and pulmonary health. The journal not only aims to bridge the gap between research and clinical practice but also to serve as a platform for innovative ideas and collaborations among researchers, healthcare professionals, and trainees. By offering unrestricted access to its articles, Clinical Medicine Insights ensures that vital knowledge reaches a broad audience, ultimately fostering advancements in medical science and patient care.

Lung India

Elevating standards in lung disease management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0970-2113Frequency: 6 issues/year

Lung India is a premier open-access journal dedicated to the dissemination of high-quality research in the field of Pulmonary and Respiratory Medicine. Published by Wolters Kluwer Medknow Publications, it has been forging a path in respiratory healthcare since its inception in 2004. With its impactful contributions to clinical practice and research, Lung India holds a solid position in the academic landscape, evidenced by its ranking in the Q3 quartile for Pulmonary and Respiratory Medicine as of 2023, and its Scopus rank of #99 out of 155. The journal is particularly important for researchers, clinicians, and students in India and beyond, providing a platform for the latest findings and developments in respiratory care, lung disease management, and innovative treatment methods. With a commitment to accessibility, Lung India aims to promote knowledge sharing among professionals and support the advancement of respiratory health. The journal is well-equipped to cater to a diverse audience, ensuring that vital research is readily accessible and impactful.

CHEST

Transforming critical care through innovative studies.
Publisher: ELSEVIERISSN: 0012-3692Frequency: 12 issues/year

CHEST is a premier journal published by Elsevier, focusing on the vital fields of cardiology, critical care, and pulmonary medicine. Established in 1970, this esteemed journal has continually provided authoritative research, reviews, and clinical studies, catering to a global audience of healthcare professionals, researchers, and students. With an impressive impact factor, CHEST ranks in the top quartile (Q1) across its core categories according to the latest Scopus metrics, securing its position as a leading resource within cardiology (Rank #16), pulmonary (Rank #9), and critical care (Rank #8). Published quarterly, it offers a wealth of knowledge essential for advancing understanding and improving patient outcomes in these critical areas of healthcare. Researchers and practitioners are encouraged to submit their work, contributing to the ongoing discourse that shapes innovative practices and policies in respiratory and cardiovascular health.

THORAX

Advancing pulmonary knowledge, one study at a time.
Publisher: BMJ PUBLISHING GROUPISSN: 0040-6376Frequency: 12 issues/year

THORAX is a premier academic journal dedicated to advancing knowledge in the field of Pulmonary and Respiratory Medicine. Published by the esteemed BMJ Publishing Group in the United Kingdom, this journal has been a pivotal resource for researchers and clinicians since its inception in 1946. With a remarkable ranking of #6 out of 155 in its category, THORAX holds a prestigious position within the top 4% of its field, as indicated by its 2023 Q1 quartile classification and a strong Scopus ranking. The journal focuses on publishing high-quality research, reviews, and clinical studies that are essential for understanding respiratory diseases and their management. Although it is not an open-access journal, THORAX provides vital contributions to the academic community, fostering dialogue and innovation in pulmonary medicine. As it approaches its converged years, concluding in 2024, researchers, professionals, and students are encouraged to explore its rich repository of knowledge, while engaging with the most current advancements in the field.

Annals of the American Thoracic Society

Pioneering the path in pulmonary and respiratory advancements.
Publisher: AMER THORACIC SOCISSN: 1546-3222Frequency: 12 issues/year

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

Respiratory Investigation

Connecting scholars to revolutionize respiratory medicine.
Publisher: ELSEVIERISSN: 2212-5345Frequency: 6 issues/year

Respiratory Investigation is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of Pulmonary and Respiratory Medicine. Since its inception in 2012, the journal has grown to become a vital resource for researchers, clinicians, and students alike, providing a platform for high-quality research articles, reviews, and clinical studies. With a commendable impact factor and ranked in the Q2 category of Scopus' 2023 metrics, it stands at rank #57 out of 155 in its field, illustrating its importance and influence within the academic community. Although the journal operates on a subscription basis, it remains committed to disseminating essential findings that enhance the understanding and treatment of respiratory diseases. Set against the innovative backdrop of the Netherlands, Respiratory Investigation not only serves as a conduit for scholarly exchange but also plays a critical role in shaping future research directions and clinical practices.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Bridging research and discovery in pulmonary studies.
Publisher: AMER PHYSIOLOGICAL SOCISSN: 1040-0605Frequency: 12 issues/year

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, published by the American Physiological Society, stands as a prominent peer-reviewed journal dedicated to advancing the field of lung cellular and molecular physiology. With an impressive impact factor, the journal serves as a crucial platform for disseminating high-quality research focused on the intricate mechanisms underlying pulmonary function and disease. Established in 1989, this journal has consistently ranked within the top quartiles across various categories, including Q1 in Physiology and Pulmonary and Respiratory Medicine, highlighting its significance in the scientific community. The journal covers a wide scope of topics pertinent to cell biology and physiology, catering to the needs of researchers, professionals, and students seeking to explore and contribute to this vital area of study. Although currently not offering open access, it provides comprehensive access options for subscribers, ensuring that vital research is communicated effectively to the global scientific community. With a commitment to fostering innovation and inspiring future studies, the AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY remains an essential resource for those engaged in lung research.

BMC Pulmonary Medicine

Advancing respiratory health through open access research.
Publisher: BMCISSN: 1471-2466Frequency: 1 issue/year

BMC Pulmonary Medicine is a leading open access journal dedicated to the field of pulmonary and respiratory medicine, published by BMC since its inception in 2001. With an ISSN of 1471-2466, this journal plays a pivotal role in advancing knowledge and research dissemination in its field, maintaining a prominent position with a 2023 Scopus ranking of #65 out of 155 journals, placing it within the 58th percentile of the category. Based in the United Kingdom, it operates under a collaborative mission to provide unrestricted access to vital research, contributing to the global understanding of respiratory health issues. The journal is recognized for its commitment to high-quality, peer-reviewed research, as evidenced by its Q2 category designation in Pulmonary and Respiratory Medicine. BMC Pulmonary Medicine aims to foster innovation and scholarship among researchers, professionals, and students, making it an indispensable resource for anyone engaged in pulmonary research and practice. The journal, accessible to everyone, enables the dissemination of impactful research that can influence clinical practice and policy worldwide.

Jornal Brasileiro de Pneumologia

Advancing respiratory health through innovative research.
Publisher: SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIAISSN: 1806-3713Frequency: 6 issues/year

Jornal Brasileiro de Pneumologia is a pivotal open-access journal in the field of Pulmonary and Respiratory Medicine, published by SOC BRASILEIRA PNEUMOLOGIA TISIOLOGIA. Established in 2004, this esteemed publication has become a significant platform for researchers, health professionals, and students in Brazil and beyond, facilitating the exchange of innovative ideas and vital research findings. The journal is indexed in Scopus and is recognized in the 2023 category quartiles as Q3, ranking 86 out of 155 in its field with a corresponding 44th percentile. This reflects its growing influence and commitment to advancing knowledge concerning respiratory health. With a mission to disseminate high-quality research, the journal aims to foster advancements in clinical practice and improve outcomes in pulmonary diseases, making it an essential resource for those dedicated to enhancing the quality of care in respiratory medicine. For those seeking comprehensive access to critical studies and reviews in this domain, the Jornal Brasileiro de Pneumologia remains an invaluable asset.

Zeitschrift fur Pneumologie

Transforming Insights into Clinical Practice
Publisher: SPRINGER HEIDELBERGISSN: 2731-7404Frequency: 6 issues/year

Zeitschrift für Pneumologie is a pivotal journal in the field of Pulmonary and Respiratory Medicine, published by Springer Heidelberg, a renowned name in academic publishing. With its ISSN number 2731-7404, it serves as a vital platform for disseminating innovative research and clinical studies relevant to lung health and diseases. This German-based journal aims to bridge the gap between research and practice, encouraging submissions that advance knowledge in respiratory medicine, including pathophysiology, treatment modalities, and patient care strategies. Although currently categorized in the Q4 quartile within its field, its commitment to quality research and emerging insights positions it as an essential resource for researchers, healthcare professionals, and students dedicated to improving respiratory health. The journal operates within the convergence period from 2022 to 2024, promising a dynamic evolution of its content. With limited open access availability, it encourages readership and contribution from its audience, fostering a collaborative academic environment.